Research Updates in Pediatric Neuroscience

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 27906

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Pediatrics, Tungs’ Taichung Metroharbor Hospital, Wuchi, Taichung 435, Taiwan
2. Department of Rehabilitation, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 356, Taiwan
3. Department of Life Sciences, Agricultural Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan
Interests: pediatric neurology; ion channel; neuropharmacology

E-Mail Website
Guest Editor
Department of Life Sciences and PhD Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan
Interests: molecular embryology; epigenetics

E-Mail Website
Guest Editor
School of Medicine, Fu-Jen Catholic University, Hsinchuang, New Taipei City 24205, Taiwan
Interests: vision; nociception

E-Mail Website
Guest Editor
Department of Pediatrics, Tungs' Taichung Metroharbor Hospital, Wuchi, Taichung 435, Taiwan
Interests: pediatric epilepsy

E-Mail Website
Guest Editor
1. Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
2. Department of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan
Interests: immunology; pediatric neurology

Special Issue Information

Dear Colleagues,

Children are the hope of the world. Any neurological or neurodevelopmental ailments can affect a child’s entire life. Pediatric neurologists are specifically trained to care for children with such disorders. However, although studies of those disorders are processed by dedicated and intelligent physicians and scientists accompanied by a cascade of novel technology, such as neuroimaging, positron emission tomograph, sophisticated genetics and lipid and amino acid chemistry, have propelled the field forward, however, no one can overall fathom the field of pediatric neurology,  which is "the innumerable rivulets that coalesce to form the river of knowledge " commentedwith emotion by Dr. Kenneth F. Swaiman.

For advances in biotechnology allows both clinical and basic researchers in this field are continuing to expand, the aim of this special issue is to introduce the recent dramatic advances in pediatric neuroscience, including epilepsy, metabolism, genetics, autism, attention-deficit hyperactivity disorder (ADHD), developmental delay,  immunology, oncology, and ophthalmology to provide a broader perspective of the diagnostic, therapeutic, and prognostic aspects of  pediatric neuroscience.

Prof. Dr. Hueng-Chuen Fan
Prof. Dr. Chuan-Mu Chen
Prof. Dr. Yih-Jing Lee
Prof. Dr. Ching-Shiang Chi
Prof. Dr. Shyi-Jou Chen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • epilepsy
  • prematurity
  • retinopathy
  • strokes
  • autism
  • attention deficit hyperactivity
  • developmental delay
  • brain tumor

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

13 pages, 29065 KiB  
Article
Whole Exome Sequencing Identifies a Novel Homozygous Missense Mutation in the CSB Protein-Encoding ERCC6 Gene in a Taiwanese Boy with Cockayne Syndrome
by Ching-Ming Lin, Jay-How Yang, Hwei-Jen Lee, Yu-Pang Lin, Li-Ping Tsai, Chih-Sin Hsu, G. W. Gant Luxton and Chih-Fen Hu
Life 2021, 11(11), 1230; https://0-doi-org.brum.beds.ac.uk/10.3390/life11111230 - 14 Nov 2021
Cited by 2 | Viewed by 1782
Abstract
Background: Cockayne syndrome (CS) is a rare form of dwarfism that is characterized by progressive premature aging. CS is typically caused by mutations in the excision repair cross-complementing protein group 6 (ERCC6) gene that encodes the CS group B (CSB) protein. [...] Read more.
Background: Cockayne syndrome (CS) is a rare form of dwarfism that is characterized by progressive premature aging. CS is typically caused by mutations in the excision repair cross-complementing protein group 6 (ERCC6) gene that encodes the CS group B (CSB) protein. Using whole exome sequencing, we recently identified a novel homozygous missense mutation (Leu536Trp) in CSB in a Taiwanese boy with CS. Since the current database (Varsome) interprets this variant as likely pathogenic, we utilized a bioinformatic tool to investigate the impact of Leu536Trp as well as two other variants (Arg453Ter, Asp532Gly) in similar articles on the CSB protein structure stability. Methods: We used iterative threading assembly refinement (I-TASSER) to generate a predictive 3D structure of CSB. We calculated the change of mutation energy after residues substitution on the protein stability using I-TASSER as well as the artificial intelligence program Alphafold. Results: The Asp532Gly variant destabilized both modeled structures, while the Leu536Trp variant showed no effect on I-TASSER’s model but destabilized the Alphafold’s modeled structure. Conclusions: We propose here the first case of CS associated with a novel homozygous missense mutation (Leu536Trp) in CSB. Furthermore, we suggest that the Asp532Gly and Leu536Trp variants are both pathogenic after bioinformatic analysis of protein stability. Full article
(This article belongs to the Special Issue Research Updates in Pediatric Neuroscience)
Show Figures

Figure 1

11 pages, 452 KiB  
Article
Lactate Predicts Neurological Outcomes after Perinatal Asphyxia in Post-Hypothermia Era: A Prospective Cohort Study
by Yi-Fang Tu, Po-Ming Wu, Wen-Hao Yu, Chung-I Li, Cheng-Lin Wu, Lin Kang, Yung-Chieh Lin, Hsin-I Shih and Chao-Ching Huang
Life 2021, 11(11), 1193; https://0-doi-org.brum.beds.ac.uk/10.3390/life11111193 - 05 Nov 2021
Cited by 4 | Viewed by 1684
Abstract
Background: Neonatal hypoxic-ischemic encephalopathy (HIE) is the most common cause of mortality and neurological disability in infancy after perinatal asphyxia. Reliable biomarkers to predict neurological outcomes of neonates after perinatal asphyxia are still not accessible in clinical practice. Methods: A prospective cohort study [...] Read more.
Background: Neonatal hypoxic-ischemic encephalopathy (HIE) is the most common cause of mortality and neurological disability in infancy after perinatal asphyxia. Reliable biomarkers to predict neurological outcomes of neonates after perinatal asphyxia are still not accessible in clinical practice. Methods: A prospective cohort study enrolled neonates with perinatal asphyxia. Biochemical blood tests and cerebral Doppler ultrasound were measured within 6 h of age and at the 4th day old. Neurological outcomes were assessed at 1 year old. Results: Sixty-four neonates with perinatal asphyxia were enrolled. Fifty-eight (90%) had hypoxic-ischemic encephalopathy (HIE) including 20 (34%) Stage I, 21 (36%) Stage II, and 17 (29%) Stage III. In the asphyxiated infants without therapeutic hypothermia, HIE stage, PH, and base excess levels within 6 h of age were the predictors of adverse outcomes. In the asphyxiated infants receiving therapeutic hypothermia, HIE stage failed to predict outcomes. Instead, blood lactate levels and pulsatility index (PI) of medial cerebral arteries (MCA) either in 6 h of age or at the 4th day old independently predicted adverse outcomes. Conclusions: Blood lactate, which is a common accessible test at the hospital and MCA PI on cerebral ultrasound could predict adverse outcomes in asphyxiated infants receiving therapeutic hypothermia. Full article
(This article belongs to the Special Issue Research Updates in Pediatric Neuroscience)
Show Figures

Figure 1

10 pages, 1156 KiB  
Article
High Risk for Attention-Deficit Hyperactive Disorder in Children with Strabismus: A Nationwide Cohort Study from the National Health Insurance Research Database
by Chia-Ying Tsai, Chien-Chia Su, Yao-Lin Liu, I-Ju Tsai and Tzu-Hsun Tsai
Life 2021, 11(11), 1139; https://0-doi-org.brum.beds.ac.uk/10.3390/life11111139 - 26 Oct 2021
Cited by 4 | Viewed by 2836
Abstract
Strabismus is associated with amblyopia and a lower quality of life. Attention-deficit hyperactivity disorder (ADHD) is common among children and adolescents, and influences their academic, vocational, and social life. Previous studies have suggested an association between strabismus and ADHD. Using data from the [...] Read more.
Strabismus is associated with amblyopia and a lower quality of life. Attention-deficit hyperactivity disorder (ADHD) is common among children and adolescents, and influences their academic, vocational, and social life. Previous studies have suggested an association between strabismus and ADHD. Using data from the Taiwan National Health Insurance Research Database between 2000 and 2010, we performed a large-scale cohort study comparing the incidence, risk factors, and severity of ADHD in children with and without strabismus. A total of 2049 patients <18 years old with newly diagnosed strabismus (esotropia: 404; exotropia: 1645) were identified, and 8196 age- and sex-matched controls without strabismus were also included. After an average of 6.5 ± 2.9 years of follow-up, the incidence of ADHD per 1000 person-years was 5.39 in the strabismus group (esotropia: 9.93; exotropia: 4.11) and 3.23 in the control group. The cumulative incidence of ADHD was significantly greater in the esotropia (hazard ratio [HR]: 2.04; 95% confidence interval [CI]:1.36–3.06; p = 0.0007) and exotropia groups (HR: 1.44; 95% CI: 1.03–2.03; p = 0.038) than in the controls. Patients with strabismus had more comorbidities than those without (p < 0.05). In summary, this large-scale study found a higher cumulative incidence of ADHD in patients with strabismus, especially in those with esotropia. Full article
(This article belongs to the Special Issue Research Updates in Pediatric Neuroscience)
Show Figures

Figure 1

10 pages, 966 KiB  
Article
Is Preterm Birth a Risk Factor for Subsequent Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder in Children with Febrile Seizure?—A Retrospective Study
by Chien-Heng Lin, Wei-De Lin, I-Ching Chou, Inn-Chi Lee and Syuan-Yu Hong
Life 2021, 11(8), 854; https://0-doi-org.brum.beds.ac.uk/10.3390/life11080854 - 20 Aug 2021
Cited by 3 | Viewed by 2324
Abstract
Febrile seizure (FS) is the most prevalent childhood seizure; it is significantly related to subsequent epilepsy and has possible links to childhood neurodevelopmental disorders. Separately, premature births are believed to increase the risk of attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder [...] Read more.
Febrile seizure (FS) is the most prevalent childhood seizure; it is significantly related to subsequent epilepsy and has possible links to childhood neurodevelopmental disorders. Separately, premature births are believed to increase the risk of attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Therefore, this study investigated whether preterm birth is a risk factor for subsequent epilepsy, ASD, and ADHD in children with FS. We retrospectively collected data for children aged < 5 years with FS from 1 January 2005, to 31 December 2013. We divided these children into two groups—the premature birth group and the full-term group—and compared their incidence rates of epilepsy, ASD and ADHD. The data of 426 patients with history of febrile convulsion were retrospectively collected. The premature birth group (FS+/preterm+) had 108 patients and the full-term group (FS+/preterm−) had 318 patients. The overall epilepsy risk in the FS+/preterm+ group was higher than in the FS+/preterm− group (odds ratio [OR], 2.52; 95% confidence interval [CI], 1.14–5.58; p = 0.02). The overall risk of ADHD in the FS+/preterm+ group was higher than that in the FS+/preterm− group (OR, 6.41; 95% CI, 3.39–12.09; p = 0.0001). In addition, children with FS+/preterm+ had 16.9 times (95% CI, 4.79–59.7; p = 0.0001) higher odds of having ASD compared with those with FS+/preterm−. Preterm birth may be a risk factor for subsequent epilepsy, ASD and ADHD in children with FS. Full article
(This article belongs to the Special Issue Research Updates in Pediatric Neuroscience)
Show Figures

Figure 1

Review

Jump to: Research

19 pages, 9865 KiB  
Review
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review
by Michela Ada Noris Ferilli, Roberto Paparella, Ilaria Morandini, Laura Papetti, Lorenzo Figà Talamanca, Claudia Ruscitto, Fabiana Ursitti, Romina Moavero, Giorgia Sforza, Samuela Tarantino, Martina Proietti Checchi, Federico Vigevano and Massimiliano Valeriani
Life 2022, 12(1), 19; https://0-doi-org.brum.beds.ac.uk/10.3390/life12010019 - 23 Dec 2021
Cited by 5 | Viewed by 4259
Abstract
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a central nervous system (CNS) inflammatory demyelinating disease characterized by recurrent inflammatory events that primarily involve optic nerves and the spinal cord, but also affect other regions of the CNS, including hypothalamus, area postrema and periaqueductal gray [...] Read more.
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a central nervous system (CNS) inflammatory demyelinating disease characterized by recurrent inflammatory events that primarily involve optic nerves and the spinal cord, but also affect other regions of the CNS, including hypothalamus, area postrema and periaqueductal gray matter. The aquaporin-4 antibody (AQP4-IgG) is specific for NMOSD. Recently, myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) have been found in a group of AQP4-IgG negative patients. NMOSD is rare among children and adolescents, but early diagnosis is important to start adequate therapy. In this report, we present cases of seven pediatric patients with NMOSD and we review the clinical and neuroimaging characteristics, diagnosis, and treatment of NMOSD in children. Full article
(This article belongs to the Special Issue Research Updates in Pediatric Neuroscience)
Show Figures

Figure 1

31 pages, 2617 KiB  
Review
Telomeres and Cancer
by Hueng-Chuen Fan, Fung-Wei Chang, Jeng-Dau Tsai, Kao-Min Lin, Chuan-Mu Chen, Shinn-Zong Lin, Ching-Ann Liu and Horng-Jyh Harn
Life 2021, 11(12), 1405; https://0-doi-org.brum.beds.ac.uk/10.3390/life11121405 - 16 Dec 2021
Cited by 13 | Viewed by 4858
Abstract
Telomeres cap the ends of eukaryotic chromosomes and are indispensable chromatin structures for genome protection and replication. Telomere length maintenance has been attributed to several functional modulators, including telomerase, the shelterin complex, and the CST complex, synergizing with DNA replication, repair, and the [...] Read more.
Telomeres cap the ends of eukaryotic chromosomes and are indispensable chromatin structures for genome protection and replication. Telomere length maintenance has been attributed to several functional modulators, including telomerase, the shelterin complex, and the CST complex, synergizing with DNA replication, repair, and the RNA metabolism pathway components. As dysfunctional telomere maintenance and telomerase activation are associated with several human diseases, including cancer, the molecular mechanisms behind telomere length regulation and protection need particular emphasis. Cancer cells exhibit telomerase activation, enabling replicative immortality. Telomerase reverse transcriptase (TERT) activation is involved in cancer development through diverse activities other than mediating telomere elongation. This review describes the telomere functions, the role of functional modulators, the implications in cancer development, and the future therapeutic opportunities. Full article
(This article belongs to the Special Issue Research Updates in Pediatric Neuroscience)
Show Figures

Figure 1

11 pages, 942 KiB  
Review
Approach to Neurological Channelopathies and Neurometabolic Disorders in Newborns
by Inn-Chi Lee
Life 2021, 11(11), 1244; https://doi.org/10.3390/life11111244 - 16 Nov 2021
Cited by 3 | Viewed by 2759
Abstract
Ion channel disorders (channelopathies) can affect any organ system in newborns before 2 months of life, including the skeletal muscle and central nervous system. Channelopathies in newborns can manifest as seizure disorders, which is a critical issue as early onset seizures can mimic [...] Read more.
Ion channel disorders (channelopathies) can affect any organ system in newborns before 2 months of life, including the skeletal muscle and central nervous system. Channelopathies in newborns can manifest as seizure disorders, which is a critical issue as early onset seizures can mimic the presentation of neurometabolic disorders. Seizures in channelopathies can either be focal or generalized, and range in severity from benign to epileptic encephalopathies that may lead to developmental regression and eventually premature death. The presenting symptoms of channelopathies are challenging for clinicians to decipher, such that an extensive diagnostic survey through a precise step-by-step process is vital. Early diagnosis of a newborn’s disease, either as a channelopathy or neurometabolic disorder, is important for the long-term neurodevelopment of the child. Full article
(This article belongs to the Special Issue Research Updates in Pediatric Neuroscience)
Show Figures

Figure 1

24 pages, 3405 KiB  
Review
Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes
by Hueng-Chuen Fan, Hsiu-Fen Lee, Chen-Tang Yue and Ching-Shiang Chi
Life 2021, 11(11), 1111; https://0-doi-org.brum.beds.ac.uk/10.3390/life11111111 - 20 Oct 2021
Cited by 10 | Viewed by 6249
Abstract
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, a maternally inherited mitochondrial disorder, is characterized by its genetic, biochemical and clinical complexity. The most common mutation associated with MELAS syndrome is the mtDNA A3243G mutation in the MT-TL1 gene encoding the mitochondrial [...] Read more.
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, a maternally inherited mitochondrial disorder, is characterized by its genetic, biochemical and clinical complexity. The most common mutation associated with MELAS syndrome is the mtDNA A3243G mutation in the MT-TL1 gene encoding the mitochondrial tRNA-leu(UUR), which results in impaired mitochondrial translation and protein synthesis involving the mitochondrial electron transport chain complex subunits, leading to impaired mitochondrial energy production. Angiopathy, either alone or in combination with nitric oxide (NO) deficiency, further contributes to multi-organ involvement in MELAS syndrome. Management for MELAS syndrome is amostly symptomatic multidisciplinary approach. In this article, we review the clinical presentations, pathogenic mechanisms and options for management of MELAS syndrome. Full article
(This article belongs to the Special Issue Research Updates in Pediatric Neuroscience)
Show Figures

Figure 1

Back to TopTop